R65G (p.Arg65Gly) variant of TLR3 (Toll-like receptor 3)

R65G (p.Arg65Gly) in TLR3 (Toll-like receptor 3) is a missense change. Clinical records from EBI and UniProt describe it as likely benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.21 / 1. The record also includes population frequency data and structural context.

R65G (p.Arg65Gly) variant details